TCBPY — TC Biopharm (Holdings) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for TC Biopharm (Holdings), fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	20-F	10-K	10-K
Standards:	IFRS	IFRS	IFRS	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.957	0.748	1.57	4.81	2.46
Net Total Accounts Receivable
Net Total Receivables	3.02	1.24	1.48	1.78	1.1
Prepaid Expenses
Total Current Assets	4.22	2.22	3.86	7.45	5.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.61	4.63	3.68	3.29	2.62
Net Intangible Assets
Total Assets	10.1	7.27	8.02	11.3	8.93
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.88	4.19	20.6	9.16	4.75
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	12.7	10.6	24.6	11	6.25
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-2.54	-3.35	-16.6	0.331	2.69
Total Liabilities & Shareholders' Equity	10.1	7.27	8.02	11.3	8.93
Total Common Shares Outstanding